1

Weigang Dong , Yan Yin ,Jianwen Qin*.Impact   of chronic obstructive pulmonary disease on the efcacy   and safety of neoadjuvant immune checkpoint inhibitors combined   with chemotherapy for resectable non-small cell lung cancer:   a retrospective cohort study.BMC Cancer (2024) 24:153

3.8

2

     Identification of Recurrent Insertions   and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor Receptor 2   as Potential Drivers in Non-Small-Cell Lung Cancer and Other Cancer Types .   JCO Precis Oncol .2022
   Feb ;6:e2100325. doi   :10.1200/PO.21.00325.

5.479

3

   Identification and Validation of a   GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma . J Oncol   .2022 May 17. doi :10.1155/2022/9054983.
  Zhenxing Feng , Yan Yin , Bin Liu , Yafang Zheng , Dongsheng Shi , Hong Zhang   , JianwenQin .

4.501

4

ZNF143 Expression is Associated   with COPD and Tumor Microenvironment in Non-Small Cell Lung Cancer . Int J   Chron Obstruct Pulmon Dis .2022 Apr 2;17:685-700.

2.893

5

     Prognostic and Immunological Role of FAT   Family Genes in Non - Small Cell Lung Cancer . Cancer Control .2022 Jan - Dec   ;29:10732748221076682. doi :10.1177/10732748221076682.

2.339

6

Multi-line treatment with   tyrosine kinase inhibitors enabled in 4-year survival for patient with stage   IV lung adenocarcinoma: a case report . Ann Palliat Med .2020 Oct 27: apm   -20-1514.    

1.925

1

EGFR阳性肺癌患者甲基化水平对 TKI 疗效影响研究

天津市卫健委

2

FAT基因家族对非小细胞肺癌免疫微环境和免疫检查点抑制剂疗效影响的临床研究

北京肿瘤防治研究会

 3

COPD对可手术非小细胞肺癌新辅助免疫联合化疗影响的研究

北京肿瘤防治研究会

4

抗肿瘤免疫相关不良事件规范化诊疗体系建设

中国医学科学院北京协和医院